<?xml version="1.0" ?>
<!--   RSS generated by the Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services on Mon, 12 Oct 2009 04:00:33 EST   --> 
<rss version="2.0">
<channel>
<title>National Quality Measures Clearinghouse (NQMC)</title>
<link>http://www.qualitymeasures.ahrq.gov/</link>
<description>The latest news from National Quality Measures Clearinghouse (NQMC), a public repository for evidence-based quality measures and measure sets.</description>
<language>en-us</language>
<copyright>Copyright 2009 National Quality Measures Clearinghouse (NQMC)</copyright>
<docs>http://blogs.law.harvard.edu/tech/rss</docs>
<lastBuildDate>Mon, 12 Oct 2009 04:00:33 EST</lastBuildDate>
<category domain="Syndic8">33928</category>
<category domain="http://www.dmoz.org">Health/Medicine/Reference/Government Agencies/</category>
<image>
<title>National Quality Measures Clearinghouse (NQMC)</title>
<url>http://www.qualitymeasures.ahrq.gov/assets/images/logo/nqmc_email_hdr.gif</url>
<link>http://www.qualitymeasures.ahrq.gov/</link>
</image>
<item>
<title>Venous Thromboembolism Diagnosis and Treatment Measures</title>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14570</link>
<author>Institute for Clinical Systems Improvement</author>
<pubDate>Thu, 01 Jan 2009 00:00:00 EST</pubDate>
</item>
<item>
<title>Retinal detachment surgery: percentage of patients having an unplanned readmission within 28 days of discharge, following retinal detachment surgery, due to endophthalmitis in the operated eye, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients having an unplanned readmission within 28 days of discharge, following retinal detachment surgery, due to endophthalmitis in the operated eye, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14060</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Refractive surgery: percentage of readmissions (related to the operated eye) within 28 days of discharge following refractive surgery, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of readmissions (related to the operated eye) within 28 days of discharge following refractive surgery, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14063</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Venous thromboembolism (VTE) diagnosis and treatment: percentage of adult patients treated for VTE who have been assessed for the need for graded compression stockings (not Teds).</title>
<description>&lt;p&gt;This measure is used to assess the percentage of adult patients treated for venous thromboembolism (VTE) who have been assessed for the need for graded compression stockings (not Teds).&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14563</link>
<author>Institute for Clinical Systems Improvement</author>
<pubDate>Wed, 01 Feb 2006 00:00:00 EST</pubDate>
</item>
<item>
<title>Venous thromboembolism (VTE) diagnosis and treatment: percentage of adult patients who have a high clinical pretest probability for pulmonary embolism (PE) who received low molecular weight heparin (LMWH) during evaluation.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients who have a high clinical pretest probability for pulmonary embolism (PE) who received low molecular weight heparin (LMWH) during evaluation.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14564</link>
<author>Institute for Clinical Systems Improvement</author>
<pubDate>Wed, 01 Feb 2006 00:00:00 EST</pubDate>
</item>
<item>
<title>Glaucoma surgery: percentage of patients having a readmission within 28 days of discharge following glaucoma surgery, due to endophthalmitis in the operated eye, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients having a readmission within 28 days of discharge following glaucoma surgery, due to endophthalmitis in the operated eye, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14057</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Retinal detachment surgery: percentage of unplanned readmissions within 28 days of discharge, following retinal detachment surgery, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of unplanned readmissions within 28 days of discharge, following retinal detachment surgery, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14059</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Refractive surgery: percentage of patients having a readmission within 28 days of discharge, following refractive surgery, due to endophthalmitis in the operated eye, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients having a readmission within 28 days of discharge following refractive surgery, due to endophthalmitis in the operated eye, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14064</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Refractive surgery: percentage of patients having an anterior vitrectomy at the time of refractive surgery, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients having an anterior vitrectomy at the time of refractive surgery, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14066</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Venous thromboembolism (VTE) diagnosis and treatment: percentage of adult patients suspected of deep vein thrombosis (DVT) who have leg duplex ultrasound with compression performed despite a low clinical pretest probability and a negative D-dimer test.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of adult patients suspected of deep vein thrombosis (DVT) who have leg duplex ultrasound with compression performed despite a low clinical pretest probability and a negative D-dimer test.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14566</link>
<author>Institute for Clinical Systems Improvement</author>
<pubDate>Wed, 01 Feb 2006 00:00:00 EST</pubDate>
</item>
<item>
<title>Venous thromboembolism (VTE) diagnosis and treatment: percentage of low-molecular-weight heparin (LMWH)-eligible patients with deep vein thrombosis (DVT) treated in an outpatient setting.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of low-molecular-weight heparin (LMWH)-eligible patients with deep vein thrombosis treated in an outpatient setting.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14568</link>
<author>Institute for Clinical Systems Improvement</author>
<pubDate>Tue, 01 Apr 2003 00:00:00 EST</pubDate>
</item>
<item>
<title>Cataract surgery: percentage of patients having a discharge intention of 1 day, who had an overnight admission following cataract surgery, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients having a discharge intention of 1 day, who had an overnight admission following cataract surgery, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14043</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Cataract surgery: percentage of patients having an anterior vitrectomy at the time of cataract surgery, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients having an anterior vitrectomy at the time of cataract surgery, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14044</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Retinal detachment surgery: percentage of patients with a total length of stay (LOS) greater than 4 days, following retinal detachment surgery, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients with a total length of stay (LOS) greater than 4 days, following retinal detachment surgery, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14061</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Retinal detachment surgery: percentage of patients having an unplanned reoperation on the same eye within 28 days, following retinal detachment surgery, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients having an unplanned reoperation on the same eye within 28 days, following retinal detachment surgery, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14062</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Glaucoma surgery: percentage of patients with a total length of stay (LOS) greater than 3 days following glaucoma surgery, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients with a total length of stay (LOS) greater than 3 days following glaucoma surgery, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14058</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Refractive surgery: percentage of patients having a discharge intention of 1 day, who had an overnight admission following refractive surgery, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients having a discharge intention of 1 day, who had an overnight admission following refractive surgery, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14065</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients with VTE receiving heparin therapy who have a baseline platelet count before starting heparin, and then a platelet count every other day for at least the first 3 days of therapy.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients with venous thromboembolism (VTE) receiving heparin therapy who have a baseline platelet count before starting heparin, and then a platelet count every other day for at least the first 3 days of therapy.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14565</link>
<author>Institute for Clinical Systems Improvement</author>
<pubDate>Wed, 01 Feb 2006 00:00:00 EST</pubDate>
</item>
<item>
<title>Cataract surgery: percentage of readmissions (related to the operated eye) within 28 days of discharge following cataract surgery, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of readmissions (related to the operated eye) within 28 days of discharge following cataract surgery, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14041</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Cataract surgery: percentage of patients having a readmission within 28 days of discharge following cataract surgery, due to endophthalmitis in the operated eye, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients having a readmission within 28 days of discharge following cataract surgery, due to endophthalmitis in the operated eye, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14042</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Glaucoma surgery: percentage of readmissions (related to the operated eye) within 28 days of discharge following glaucoma surgery, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of readmissions (related to the operated eye) within 28 days of discharge following glaucoma surgery, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14056</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Refractive surgery: percentage of patients having a complication (medical or surgical) within 28 days following excimer laser surgery, during the 6 month time period.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients having a complication (medical or surgical) within 28 days following excimer laser surgery, during the 6 month time period.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14067</link>
<author>Australian Council on Healthcare Standards</author>
<pubDate>Wed, 01 Jan 1997 00:00:00 EST</pubDate>
</item>
<item>
<title>Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients diagnosed with VTE who meet the criteria for low-molecular-weight heparin (LMWH) and for whom LMWH is used.</title>
<description>&lt;p&gt;This measure is used to assess the percentage of patients diagnosed with venous thromboembolism (VTE) who meet the criteria for low-molecular-weight heparin (LMWH) and for whom LMWH is used.&lt;/p&gt;</description>
<link>http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=14567</link>
<author>Institute for Clinical Systems Improvement</author>
<pubDate>Tue, 01 Apr 2003 00:00:00 EST</pubDate>
</item>
</channel>
</rss>
